[Speculation] what happens to the research-peptide supply chain if this lands
what happens to the research-peptide supply chain if this lands. I am not trying to be the "source?" guy. I would just like a source.
Read both programme names carefully after mixing them up in a comment and being politely corrected.
Went looking for independent testing on this and found essentially nothing, which was clarifying.
Daily rather than weekly sounds trivial until you think about what a missed dose means in each case.
Tell me where this is wrong. That is the useful part of posting it.
best — the order this archive was captured in
Because it is not a peptide, it is not subject to the same degradation pathways, does not require the absorption enhancers used for oral peptides, and can be formulated as a conventional tablet.
the boards keep comparing it to injectables at matched doses, which is meaningless
Holding off on any opinion until phase 3 reports. That is not a satisfying position and it is the honest one.
This. The absence of food and water timing restrictions is the practical difference people will actually notice.
nothing containing this is approved anywhere yet
Daily dosing, so what does the exposure profile look like across the day?
Cosigning on daily dosing. It changes the exposure profile and it changes adherence, in both directions.
daily dosing changes adherence in both directions